Additional India-based business development staff added to meet increased demand
MUMBAI (August 27, 2012) – NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary supplement, food, water, and consumer products industries, is the first to offer Secondary Reference Standards in India, helping meet the growing India pharmaceutical sectors’ need for high quality, economical alternatives to pharmacopoeia standards.
India has one of the fastest growing pharmaceutical markets in the world. Currently ranked 14th, India’s pharma market is expected to grow by $14 billion, becoming the 10th largest pharma market by 2015.* NSF International has expanded Secondary Reference Standards to pharmaceutical companies in India to help them demonstrate the identity, purity, quality and strength of their pharmaceutical products and ingredients. In addition, to meet growing U.S. Food and Drug Administration (FDA) concerns regarding the control of impurities in pharmaceutical dosage forms, NSF is releasing test kits that will include the Active Pharmaceutical Ingredient (API) as well as all pharmacopeial listed impurities.
As required by US and EU regulations, a secondary reference standard must be demonstrated to be traceable to the primary standard (USP or EP) through laboratory testing. Unlike other secondary standards, NSF Secondary Reference Standards are qualified through a unique process that requires a minimum of three collaborating laboratories and an independent expert technical review board that approves all NSF standards before their use. As this level of characterization is unsurpassed by other secondary standards providers, NSF Secondary Reference Standards are widely accepted by international regulatory authorities and traceable to both US and EU Pharmacopoeia standards (USP and EP). Purchasers also benefit from a 40-50 percent cost savings over purchasing USP and EP standards.
To help manage the increasing demand of NSF Secondary Reference Standards in India, NSF International has hired two new Business Development Managers based out of Mumbai and Hyderabad.
Haresh B. Jeswani has more than 12 years of experience in the pharmaceutical formulation and reference standards industry in India. His experience includes working with India-based reference standards organization Kamal Udyog, as well as pharmaceutical companies such as Biological E Limited, and J.B. Chemicals & Pharmaceuticals Ltd., and the Dana Group. He earned a BSc in Chemistry from Mumbai University and Post Graduate Diplomas in Marketing Management and Import Export Management from L.N. Welingkar Institute of Management Development and Research in Mumbai.
Ajay K. Goud has nearly 6 years of experience in the pharmaceutical and biotechnology industry. His background includes working for leading India-based biotechnology firm Performance Plastics of Saint Gobain, as well as reference standards company LGC Promochem India Pvt. Ltd. He earned a MSc in Biotechnology from Bangalore University in Bangalore, India, and a BSc in Microbiology, Genetics and Chemistry from Osmania University in Hyderabad, India.
“NSF Secondary Reference Standards set the bar for the quality and purity of pharmaceutical products while also offering companies in India favorable pricing,” said Lori Bestervelt, Ph.D., NSF Chief Technical Officer and Senior Vice President over the NSF Health Sciences Division. “Mr. Jeswani and Mr. Goud both have considerable expertise in Pharmaceutical quality and provide NSF customers in India and throughout southeast Asia with unsurpassed service and access to high quality NSF Reference Standards as well as other important training, testing and consulting services through NSF’s global health sciences division.”
In addition to NSF Reference Standards, the NSF International's Health Sciences Division offers training and education, consulting, GMP and GLP testing, certification, R&D, auditing and regulatory guidance for the pharmaceutical, dietary supplement and medical device industries throughout the entire product lifecycle. The NSF Health Sciences Division includes: NSF-DBA, which has more than 25 years of pharmaceutical, dietary supplement and medical devices training expertise; NSF Pharmalytica, a GLP & GMP contract laboratory; Becker & Associates Consulting, Inc., a leading clinical, regulatory and scientific consulting firm that specializes in U.S. FDA-regulated industries; and the NSF Dietary Supplements Certification Program. NSF International developed the only American National Standard for Dietary Supplements (NSF/ANSI 173) and tests and certifies supplements against this standard.
For additional information about NSF Reference Standards or to place an order, visit www.nsf-rs.org or contact Robert Rhodes (U.S.) at email@example.com, Haresh Jeswani (India) at firstname.lastname@example.org, or Ajay Goud (India) at email@example.com.
Editor’s note: To schedule an interview with NSF Reference Standards General Manager Steven Lane, contact Kelly Nichols at firstname.lastname@example.org or +1 734-827-6850.
About NSF International: NSF International is an independent organization that writes standards, and tests and certifies products for the health science, food, water and consumer goods industries to minimize adverse health effects and protect the environment (nsf.org). Founded in 1944, NSF is committed to protecting human health and safety worldwide. NSF is a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment.
Additional NSF International services include management systems registrations, such as ISO 13485 registration for medical devices, delivered through NSF International Strategic Registrations (NSF-ISR); food safety and quality programs through the NSF Food Safety Division; drinking water product certification through the NSF Water Division; sustainability services through NSF Sustainability, and NSF Education and Training programs.
CONTACT: Kelly Nichols
Phone: +1 734-827-6850
* Kumra, Gautam, Palash Mitra, and Chandrika Pasricha. India Pharma 2015: Unlocking the Potential of the Indian Pharmaceutical Market. Rep. McKinsey & Company. Web. <http://www.mckinsey.com/locations/india/mckinseyonindia/pdf/india_pharma_2015.pdf>.